Stay updated with breaking news from Roivant Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Roivant entered into a definitive agreement with Roche for the sale of Telavant for $7.1B upfront and a milestone payment of $150M payable upon the initiation of a Phase 3 trial in ulcerative...
Roivant Sciences has reported a third-quarter earnings miss but revenue that topped analysts’ expectations, sending its shares higher in Monday premarket...
These are the stocks posting the largest moves in early trading.
Top Wall Street analysts collectively agree that these stocks have space to run higher.
BASEL, Switzerland and LONDON and NEW YORK, Nov. 10, 2023 -- Roivant today announced the appointment of Mayukh Sukhatme, M.D., to its Board of Directors, effective immediately. Dr. Sukhatme will...